Weiva Sieh, MD, PhD, MS
- SENIOR FACULTY | Population Health Science and Policy
- SENIOR FACULTY | Genetics and Genomic Sciences
Dr. Sieh’s research focuses on identifying genetic and epidemiologic factors underlying cancer susceptibility and outcomes. Current interests include:
1) Genetic and environmental determinants of mammographic breast density; relationship of breast density and other image features to breast cancer risk.
2) Genomic risk prediction using machine learning methods.
3) Risk and prognosis of hormone-related cancers, including cancers of the breast, ovary and prostate.
Education
BA Biology, Harvard University
MD Medicine, McGill University
MS Biostatistics, University of Washington
PhD Epidemiology, University of Washington
Postdoc Statistical Genetics, University of Washington
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Sieh did not report having any of the following types of financial relationships with industry during 2018 and/or 2019: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.